Arginyltransferase 1 (ATE1) Peptide
-
- Target See all ATE1 products
- ATE1 (Arginyltransferase 1 (ATE1))
- Peptide Type
- Synthetic
- Origin
- Mammalian
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB), Immunohistochemistry (IHC)
- Sequence
- CCPQYTIRCR PLQFQPSKSH KKVLKKMLKF LAKGEVPKGS CEDEPMDSTM
- Characteristics
-
A synthetic peptide for use as a blocking control in assays to test for specificity of ATE1 antibody,
Alternative Names: ATE1 control peptide, ATE1 antibody Blocking Peptide, Anti-ATE1 Blocking Peptide, Arginyltransferase 1 Blocking Peptide, MGC26724 Blocking Peptide
-
-
- Application Notes
- Optimal conditions should be determined by the investigator
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
- Buffer
- PBS
- Handling Advice
- Avoid repeated freeze/thaw cycles.
- Storage
- -20 °C
- Storage Comment
- Store at -20 °C long term.
-
- Target
- ATE1 (Arginyltransferase 1 (ATE1))
- Synonyms
- ATE1 Peptide, Ate Peptide, CG9204 Peptide, Dm-Ate1 Peptide, Dmel\\CG9204 Peptide, ate1 Peptide, l(2)k10809 Peptide, zgc:158849 Peptide, AI225793 Peptide, AW547406 Peptide, CG9204 gene product from transcript CG9204-RA Peptide, arginyltransferase 1 Peptide, arginyltransferase 1 L homeolog Peptide, Ate1 Peptide, ATE1 Peptide, ate1 Peptide, ate1.L Peptide
- Background
- ATE1 is an arginyltransferase, an enzyme that is involved in posttranslational conjugation of arginine to N-terminal aspartate or glutamate residues. Conjugation of arginine to the N-terminal aspartate or glutamate targets proteins for ubiquitin-dependent degradation. Alternative splicing results in two transcript variants encoding distinct isoforms.
- Molecular Weight
- 59 kDa
-